ADRB3 and non-small cell lung carcinoma: ADRB3 expression in monocytes and lymphocytes of bone marrow increased significantly in NSCLC compared with healthy control (MFI 11.7 ± 1.6 versus 2.2 ± 0.6, P < 0.01; 2.1 ± 0.2 versus 0.6 ± 0.1, P < 0.01, respectively, Fig. 3a–c).